Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling
Journal of Allergy and Clinical Immunology · 2023
DOI: 10.1016/j.jaci.2023.01.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Xin Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Jeff and Penny Vinik Center for Translational Immunology Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston,…. Hauptthemen laut MEDLINE: Sinusitis, Nasal Polyps, Rhinitis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a type 2 (T2) inflammatory disease associated with an increased number of airway basal cells (BCs). Recent studies have identified transcriptionally distinct BCs, but the molecular pathways that support or inhibit human BC proliferation and differentiation are largely unknown. OBJECTIVE: We sought to determine the role of T2 cytokines in regulating airway BCs. METHODS: Single-cell and bulk RNA sequencing of sinus and lung airway epithelial cells was analyzed. Human sinus BCs were stimulated with IL-4 and IL-13 in the presence and absence of inhibitors of IL-4R signaling. Confocal analysis of human sinus tissue and murine airway was performed. Murine BC subsets were sorted for RNA sequencing and functional assays. Fate labeling was performed in a murine model of tracheal injury and regeneration. RESULTS: Two subsets of BCs were found in human and murine respiratory mucosa distinguished by the expression of basal cell adhesion molecule (BCAM). BCAM expression identifies airway stem cells among P63+KRT5+NGFR+ BCs. In the sinonasal mucosa, BCAMhi BCs expressing TSLP, IL33, CCL26, and the canonical BC transcription factor TP63 are increased in patients with CRSwNP. In cultured BCs, IL-4/IL-13 increases the expression of BCAM and TP63 through an insulin receptor substrate-dependent signaling pathway that is increased in CRSwNP. CONCLUSIONS: These findings establish BCAM as a marker of airway stem cells among the BC pool and demonstrate that airway epithelial remodeling in T2 inflammation extends beyond goblet cell metaplasia to the support of a BC stem state poised to perpetuate inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jeff and Penny Vinik Center for Translational Immunology Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass.
- Department of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Boston, Mass.
- Department of Otolaryngology, Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Mass.
- Center for Data Sciences, Brigham and Women's Hospital, Boston, Mass; Divisions of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; Rheumatology, Inflammation, and…
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Mass; Division of Immunology, Boston Children's Hospital, Boston, Mass.
- Jeff and Penny Vinik Center for Translational Immunology Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass. E…
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Wang, X., Hallen, N. R., Lee, M., Samuchiwal, S., Ye, Q., Buchheit, K. M., Maxfield, A. Z., Roditi, R. E., Bergmark, R. W., Bhattacharyya, N., Ryan, T., Gakpo, D., Raychaudhuri, S., Dwyer, D., Laidlaw, T. M., Boyce, J. A., Gutierrez-Arcelus, M., & Barrett, N. A. (2023). Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.01.030
Vancouver
Wang X, Hallen NR, Lee M, Samuchiwal S, Ye Q, Buchheit KM, et al. Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.01.030
BibTeX
@article{Wang2023,
author = {Wang, Xin and Hallen, Nils R and Lee, Minkyu and Samuchiwal, Sachin and Ye, Qihua and Buchheit, Kathleen M and Maxfield, Alice Z and Roditi, Rachel E and Bergmark, Regan W and Bhattacharyya, Neil and Ryan, Tessa and Gakpo, Deb and Raychaudhuri, Soumya and Dwyer, Dan and Laidlaw, Tanya M and Boyce, Joshua A and Gutierrez-Arcelus, Maria and Barrett, Nora A},
title = {Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
doi = {10.1016/j.jaci.2023.01.030}
}
EUVIMED